These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1939964

  • 21. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS).
    Neuhaus KL, von Essen R, Tebbe U, Vogt A, Roth M, Riess M, Niederer W, Forycki F, Wirtzfeld A, Maeurer W.
    J Am Coll Cardiol; 1992 Apr; 19(5):885-91. PubMed ID: 1552106
    [Abstract] [Full Text] [Related]

  • 22. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D.
    Ann Intern Med; 1990 Apr 01; 112(7):529-38. PubMed ID: 2107781
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.
    Genser N, Lechleitner P, Maier J, Dienstl F, Artner-Dworzak E, Puschendorf B, Mair J.
    Clin Chem; 1998 Feb 01; 44(2):209-14. PubMed ID: 9474013
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thrombolysis in acute myocardial infarction.
    Holmberg SR.
    Br J Hosp Med; 1998 Feb 01; 47(8):572-6, 578-80. PubMed ID: 1591557
    [Abstract] [Full Text] [Related]

  • 28. Thrombolytic therapy in Europe: current status.
    Vahanian A.
    Eur Heart J; 1996 Sep 01; 17 Suppl E():21-7. PubMed ID: 11824000
    [Abstract] [Full Text] [Related]

  • 29. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ, Grimm AM, Hopkins LE.
    Pharmacotherapy; 1990 Sep 01; 10(2):115-26. PubMed ID: 2140889
    [Abstract] [Full Text] [Related]

  • 30. Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators.
    Karagounis LA, Anderson JL, Sorensen SG, Moreno FL.
    Am J Cardiol; 1994 Jan 01; 73(1):16-22. PubMed ID: 8279371
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Myocardial infarction, thrombolytic therapy, and economics.
    Conti RC.
    Clin Cardiol; 1993 Sep 01; 16(9):635. PubMed ID: 8242906
    [No Abstract] [Full Text] [Related]

  • 33. Which thrombolytic agent should one choose?
    Topol EJ.
    Prog Cardiovasc Dis; 1991 Sep 01; 34(3):165-78. PubMed ID: 1947122
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Fibrinolytic agents--who benefits when?].
    Weichert W, Seifried E.
    Ther Umsch; 1995 Oct 01; 52(10):652-60. PubMed ID: 7482376
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.
    Munkvad S, Jespersen J, Gram J, Kluft C.
    J Am Coll Cardiol; 1991 Mar 15; 17(4):957-62. PubMed ID: 1900313
    [Abstract] [Full Text] [Related]

  • 40. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Verh K Acad Geneeskd Belg; 1989 Mar 15; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.